Ebpay生命医药出版社

Ebpay生命

100763

论文已发表

提 交 论 文


注册即可获取Ebpay生命的最新动态

注 册



IF 收录期刊



  • 3.3 Breast Cancer (Dove Med Press)
  • 3.4 Clin Epidemiol
  • 2.5 Cancer Manag Res
  • 2.9 Infect Drug Resist
  • 3.5 Clin Interv Aging
  • 4.7 Drug Des Dev Ther
  • 2.7 Int J Chronic Obstr
  • 6.6 Int J Nanomed
  • 2.5 Int J Women's Health
  • 2.5 Neuropsych Dis Treat
  • 2.7 OncoTargets Ther
  • 2.0 Patient Prefer Adher
  • 2.3 Ther Clin Risk Manag
  • 2.5 J Pain Res
  • 2.8 Diabet Metab Synd Ob
  • 2.8 Psychol Res Behav Ma
  • 3.0 Nat Sci Sleep
  • 1.8 Pharmgenomics Pers Med
  • 2.7 Risk Manag Healthc Policy
  • 4.2 J Inflamm Res
  • 2.1 Int J Gen Med
  • 4.2 J Hepatocell Carcinoma
  • 3.7 J Asthma Allergy
  • 1.9 Clin Cosmet Investig Dermatol
  • 2.7 J Multidiscip Healthc



更多详情 >>





已发表论文

微小 RNA-18b-5p 顺利获得下调 TRAF5 抑制前列腺癌的恶性进展

 

Authors Wang X , Yu X, Wang Y, Lian J, Li Z, Dong C, Song H, Zhang L, Zhang H, Wang Y

Received 6 September 2024

Accepted for publication 11 March 2025

Published 31 March 2025 Volume 2025:18 Pages 1831—1843

DOI http://doi.org/10.2147/IJGM.S494962

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Professor Kenneth Adler

Xiaoran Wang,1 Xin Yu,2 Yong Wang,1 Jihu Lian,1 Zhenxiao Li,2 Chunli Dong,2 Haitao Song,2 Liangliang Zhang,2 Haitao Zhang,2 Yongjie Wang2 

1Urology Surgery, The People Hospital of Jilin Province (Jilin Province Clinical Research Center of Emergency and Critical Diseases), Changchun, Jilin, 130021, People’s Republic of China; 2Intensive Care Unit, The People Hospital of Jilin Province (Jilin Province Clinical Research Center of Emergency and Critical Diseases), Changchun, Jilin, 130021, People’s Republic of China

Correspondence: Yongjie Wang, Intensive Care Unit, The People Hospital of Jilin Province (Jilin Province Clinical Research Center of Emergency and Critical Diseases), 1183 Gongnong Road, Changchun, Jilin, 130021, People’s Republic of China, Tel +86-0431-85595089, Email Wangyongjie5918@163.com

Objective: Extensive efforts have been made for translating the mechanisms of microRNAs (miRNAs) in prostate cancer (PCa). However, the specific role of miR-18b-5p in PCa is still in obscurity. Herein, miR-18b-5p/TRAF5 axis-oriented exploration in PCa has been launched.
Methods: miR-18b-5p and TRAF5 expression in PCa tissues and cells was detected by RT-qPCR. In-vitro experiments were conducted to investigate the biological functions of miR-18b-5p and TRAF5 in PCa cells. The underlying mechanism of miR-18b-5p was revealed by luciferase reporter assay, miRNA Pull down, RT-qPCR, and rescue assay.
Results: Lower miR-18b-5p and higher TRAF5 expression were observed in PCa tissues and cell lines. miR-18b-5p overexpression or TRAF5 downregulation impaired proliferation, diminished migratory and invasive properties, as well as advanced apoptosis in PCa cells. miR-18b-5p could regulate TRAF5 expression by directly binding to its 3′-untranslated region. Overexpression of TRAF5 abolished the suppressive effects of restored miR-18b-5p on PCa cell progression.
Conclusion: This study elucidates that upregulated miR-18b-5p impedes PCa cell progression via downregulating TRAF5, which may provide a novel therapeutic basis for PCa.

Keywords: prostate cancer, microRNA-18b-5p, TRAF5, proliferation, invasion, migration, apoptosis

Download Article[PDF]